John Gallagher is the President & CEO of Clean Bite, Inc., a Delaware Corporation that has transitioned from Clean Bite, LLC, to manage the company's 28 international patents better. Clean Bite™ products have been developed, prototyped, and patented in the United States, EU (et al.: UK, Norway, Switzerland, Liechtenstein), and India. Clean Bite™ products, with their innovative approach, initially focused on providing a period of utility, allowing people and companion pets to brush their teeth by simply chewing them. The term 'toothbrush' may be used, but it's a paradox. Only a visual representation of these products can correct the familiarity we all have with the word 'toothbrush '. These products, with a completely different geometry, were first developed from formulations that are foodstuffs (gel-based). After the utility period, they dissolve and are swallowed. The product formulations were expanded to non-soluble formulations to accommodate different factors that needed consideration. Under Gallagher's leadership, Clean Bite, Inc. has not only developed innovative products but also established key partnerships. Gallagher’s most notable achievement was creating a relationship with Amit Goswamy, CEO of Livionex, Inc., of Los Gatos, CA, makers of LivFresh Dental Gel toothpaste. LivFresh, the dentifrice used in every Clean Bite™ product, is the only OTC toothpaste to be awarded a CE Mark in the EU, recommended for the prevention and treatment of gingivitis and periodontitis. LivFresh's effectiveness is underscored by its ability to remove 250% more plaque than products considered to be the Gold Standard, as shown in multiple studies. LivFresh holds over 40 international patents, further demonstrating its quality and effectiveness.This performance speaks volumes in the human markets, and for pet parents, the statistics are simple: 80% of dogs and 70% of cats develop periodontal disease at three years of age. The IP is defensible throughout much of the world, in countries with combined populations exceeding 2.25 billion people. One more significant item is that all the food formulation products can act as a delivery system for API (Active Pharmaceutical Ingredient). In the developing world, this has far-reaching applications for remote populations. Clean Bite, Inc.’s next realm is to be involved in R&D on NTDs (Neglected Tropical Diseases). For more information, visit www.CleanBiteTM.com Additional interests:• Licensing• M&A• Joint Venture• Contract Manufacturing